[Pharmacokinetics of the new aminoglycoside antibiotics: tobramycin, lividomycin, amikacin, sisomicin in the patient with normal renal function and in renal insufficiency. Dosage rules].
D000583:Amikacin / Q000008:administration & dosage / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000378:metabolism*; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D010303:Paromomycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism*; D006435:Renal Dialysis; D012853:Sisomicin / Q000008:administration & dosage / Q000378:metabolism*; D014031:Tobramycin / Q000008:administration & dosage / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D007612:Kanamycin; D010303:Paromomycin; D000583:Amikacin; D014031:Tobramycin; D012853:Sisomicin
Pharmacocinétique des nouveaux antibiotiques du groupe des aminosides: tobramycine, lividomycine, amikacine, sisomycine chez le sujet à fonction rénale normale et chez l'insuffisant rénal. Règles de posologie.